Artal Group’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-500,500
| Closed | -$31K | – | 144 |
|
|
2022
Q2 | $31K | Hold |
500,500
| – | – | ﹤0.01% | 132 |
|
|
2022
Q1 | $826K | Hold |
500,500
| – | – | 0.03% | 126 |
|
|
2021
Q4 | $1.2M | Hold |
500,500
| – | – | 0.03% | 132 |
|
|
2021
Q3 | $2.73M | Hold |
500,500
| – | – | 0.06% | 124 |
|
|
2021
Q2 | $3.72M | Hold |
500,500
| – | – | 0.08% | 118 |
|
|
2021
Q1 | $4.05M | Hold |
500,500
| – | – | 0.07% | 114 |
|
|
2020
Q4 | $4.56M | Hold |
500,500
| – | – | 0.1% | 103 |
|
|
2020
Q3 | $5.54M | Hold |
500,500
| – | – | 0.13% | 82 |
|
|
2020
Q2 | $3.72M | Hold |
500,500
| – | – | 0.1% | 97 |
|
|
2020
Q1 | $3.08M | Hold |
500,500
| – | – | 0.13% | 79 |
|
|
2019
Q4 | $2.51M | Sell |
500,500
-400,000
| -44% | -$2.01M | 0.1% | 79 |
|
|
2019
Q3 | $6.78M | Hold |
900,500
| – | – | 0.27% | 52 |
|
|
2019
Q2 | $10.4M | Sell |
900,500
-46,919
| -5% | -$544K | 0.42% | 40 |
|
|
2019
Q1 | $13.7M | Buy |
+947,419
| New | +$13.7M | 0.56% | 33 |
|